Journal ArticleJCO Clin Cancer Inform · January 2020
PURPOSE: More than 20% of US clinical trials fail to accrue sufficiently. Our purpose was to provide a benchmark for better understanding clinical trial enrollment feasibility and to assess relative levels of competition for patients by cancer diagnosis. M ...
Full textOpen AccessLink to itemCite
ConferenceJournal of Clinical Oncology · October 20, 2018
Featured Publication
20 Background: More than 20% of US clinical trials fail to accrue sufficient patients and terminate prematurely, impeding innovation and negating the valuable contributions of participating patients. The aim of this study is to e ...
Full textCite
